Association of genetic risk severity with ADHD clinical characteristics

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 7, 2013, Pages 718-733

  Kotte, Amelia ^a,b   Faraone, Stephen V ^c   Biederman, Joseph ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Attention deficit disorder (ADD); Attention deficit hyperactivity disorder (ADHD); DRD4, DAT1, SERT, 5 HTTLPR; Genetic risk alleles; Genetic risk severity

Indexed keywords

3' UNTRANSLATED REGION; 5 HTT GENE; AGORAPHOBIA; ALLELE; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CASE CONTROL STUDY; CAUCASIAN; CHILD; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; DAT1 GENE; DEMOGRAPHY; DISRUPTIVE BEHAVIOR; DOPAMINE 4 RECEPTOR GENE; DOPAMINE TRANSPORTER 1 GENE; DRD4 GENE; EDUCATION; EXON; FAMILY STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC RISK SEVERITY SCORE; GENOTYPE; GLOBAL ASSESSMENT OF FUNCTIONING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPPOSITIONAL DEFIANT DISORDER; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE; SCHOOL CHILD; SEROTONIN TRANSPORTER 5 GENE; VARIABLE NUMBER OF TANDEM REPEAT;

ATTENTION DEFICIT DISORDER (ADD); ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD); DRD4, DAT1, SERT, 5-HTTLPR; GENETIC RISK ALLELES; GENETIC RISK SEVERITY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD BEHAVIOR; CLUSTER ANALYSIS; COMORBIDITY; DEMOGRAPHY; EMOTIONS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 84885700985     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32171     Document Type: Article

References (97)

1. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, 4th edition-text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
2. Anney RJ, Lasky-Su J, O'Dushlaine C, Kenny E, Neale BM, Mulligan A, Franke B, Zhou K, Chen W, Christiansen H, Arias-Vasquez A, Banaschewski T, Buitelaar J, Ebstein R, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen H, Asherson P, Faraone SV, Gill M. 2008. Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. Am J Med Genet Part B 147B:1369-1378.
3. Bakermans-Kranenburg MJ, Van IMH, Pijlman FT, Mesman J, Juffer F. 2008. Experimental evidence for differential susceptibility: Dopamine D4 receptor polymorphism (DRD4 VNTR) moderates intervention effects on toddlers' externalizing behavior in a randomized controlled trial. Dev Psychol 44:293-300.
4. Barber S, Grubbs L, Cottrell B. 2005. Self-perception in children with attention deficit/hyperactivity disorder. J Pediatr Nurs 20:235-245.
5. Barkley RA, Smith KM, Fischer M, Navia B. 2006. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TAQI A2, and DAT1 40 BP VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet Part B 141B:487-498.
6. Barr CL, Wigg K, Malone M, Schachar R, Tannock R, Roberts W, Kennedy JL. 1999. Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am J Med Genet 88:710-713.
7. Biederman J, Faraone SV, Weber W, Russell RL, Rater M, Park KS. 1997. Correspondence between DSM-III-R and DSM-IV attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36:1682-1687.
8. Biederman J, Monuteaux M, Mick E, Spencer T, Wilens T, Klein K, Price JE, Faraone SV. 2006a. Psychopathology in females with attention-deficit/hyperactivity disorder: A controlled, five-year prospective study. Biol Psychiatry 60:1098-1105.
9. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, Snyder LE, Faraone SV. 2006b. Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year follow-up study. Psychol Med 36:167-179.
10. Biederman J, Petty CR, Dolan C, Hughes S, Mick E, Monuteaux MC, Faraone SV. 2008. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: Findings from a controlled 10-year prospective longitudinal follow-up study. Psychol Med 38:1027-1036.
11. Biederman J, Spencer T, Lomedico A, Day H, Petty CR, Faraone SV. 2012. Deficient emotional self-regulation and pediatric attention deficit hyperactivity disorder: A family risk analysis. Psychol Med 42:639-646.
12. Castellanos FX, Lau E, Tayebi N, Lee P, Long RE, Giedd JN, Sharp W, Marsh WL, Walter JM, Hamburger SD, Ginns EI, Rapoport JL, Sidransky E. 1998. Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: Genetic and brain morphometric analyses. Mol Psychiatry 3:431-434.
13. Cross-Disorder Group of the Psychiatric GWAS Consortium. In press. Genome-wide analysis identifies loci with shared effects on five major psychiatric disorders. Lancet. 381:1371-1379.
14. Chakravarti A. 1999. Population genetics-making sense out of sequence. Nat Genet 21:56-60.
15. Christiansen H, Chen W, Oades RD, Asherson P, Taylor EA, Lasky-Su J, Zhou K, Banaschewski T, Buschgens C, Franke B, Gabriels I, Manor I, Marco R, Muller UC, Mulligan A, Psychogiou L, Rommelse NN, Uebel H, Buitelaar J, Ebstein RP, Eisenberg J, Gill M, Miranda A, Mulas F, Roeyers H, Rothenberger A, Sergeant JA, Sonuga-Barke EJ, Steinhausen HC, Thompson M, Faraone SV. 2008. Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: Familial evidence for a distinct disorder. J Neural Transm 115:163-175.
16. Coghill D. 2010. The impact of medications on quality of life in attention-deficit hyperactivity disorder: A systematic review. CNS Drugs 24:843-866.
17. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Chiu F, Wang E, Farwell K, Darakjy S, Baker R, Dietz G, Saucier G, MacMurray JP. 2000a. Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder. Clin Genet 58:31-40.
18. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Dietz G, Saucier G, MacMurray JP. 2000b. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: Multivariate regression analysis of 20 genes. Clin Genet 57:178-196.
19. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL. 1995. Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998.
20. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A, Huckett L, Sharp J, Batten C, Fernando S, Ozbay F, Yazgan Y, Simonoff E, Thompson M, Taylor E, Asherson P. 2001. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 6:425-428.
21. Derks EM, Dolan CV, Hudziak JJ, Neale MC, Boomsma DI. 2007. Assessment and etiology of attention deficit hyperactivity disorder and oppositional defiant disorder in boys and girls. Behav Genet 37:559-566.
22. DeYoung CG, Peterson JB, Seguin JR, Mejia JM, Pihl RO, Beitchman JH, Jain U, Tremblay RE, Kennedy JL, Palmour RM. 2006. The dopamine D4 receptor gene and moderation of the association between externalizing behavior and IQ. Arch Gen Psychiatry 63:1410-1416.
23. Doyle AE, Faraone S. 2002. Familial links between ADHD, conduct disorder and bipolar disorder. Curr Psychiatry Rep 4:146-152.
24. Eaves L, Rutter M, Silberg JL, Shillady L, Maes H, Pickles A. 2000. Genetic and environmental causes of covariation in interview assessments of disruptive behavior in child and adolescent twins. Behav Genet 30:321-334.
25. Faraone SV, Khan SA. 2006. Candidate gene studies of attention-deficit/hyperactivity disorder. J Clin Psychiatry 67:13-20.
26. Faraone SV, Biederman J, Weiffenbach B, Keith T, Chu MP, Weaver A, Spencer TJ, Wilens TE, Frazier J, Cleves M, Sakai J. 1999. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry 156:768-770.
27. Faraone SV, Biederman J, Monuteaux MC. 2000a. Attention-deficit disorder and conduct disorder in girls: evidence for a familial subtype. Biological Psychiatry 48:21-29.
28. Faraone SV, Biederman J, Monuteaux MC. 2000b. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genet Epidemiol 18:1-16.
29. Faraone SV, Doyle AE, Mick E, Biederman J. 2001. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 158:1052-1057.
30. Faraone SV, Sergeant J, Gillberg C, Biederman J. 2003. The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2:104-113.
31. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313-1323.
32. Faraone SV, Doyle AE, Lasky-Su J, Sklar PB, D'Angelo E, Gonzalez-Heydrich J, Kratochvil C, Mick E, Klein K, Rezac AJ, Biederman J. 2007. Linkage analysis of attention deficit hyperactivity disorder. Am J Med Genet Part B 147B(1):1387-1391.
33. Ficks CA, Waldman ID. 2009. Gene-environment interactions in attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 11:387-392.
34. First M, Spitzer R, Gibbon M, Williams J. 1997. Structured clinical interview for DSM-IV axis I disorders. Washington, DC: American Psychiatric Press.
35. Gizer IR, Ficks C, Waldman ID. 2009. Candidate gene studies of ADHD: A meta-analytic review. Hum Genet 126:51-90.
36. Grizenko N, Fortier ME, Zadorozny C, Thakur G, Schmitz N, Duval R, Joober R. 2012. Maternal stress during pregnancy, ADHD symptomatology in children and genotype: Gene-environment interaction. J Can Acad Child Adolesc Psychiatry 21:9-15.
37. Hamshere ML, Langley KL, Martin J, Agah SS, Stergiakouli E, Anney RJL, Buitelaar J, Faraone SV, Lesch KP, Neale BM, Willcutt E, Franks B, Sonuga-Barke E, Asherson P, Merwood A, Medland SE, Ripke S, Dal M, Steinhausen H, Freitag C, Reif A, Renner TJ, Nguyen TT, Romanos M, Romanos J, Walitza S, Schafer H, Warnke A, Meyer J, Palmason H, Vasquez AA, Lambregts-Rommelse N, Gill M, Sergeant J, Roeyers H, Mick E, Biederman J, Doyle A, Smalley S, Loo S, Hakonarson H, Elia J, Todorov A, Miranda A, Mulas F, Ebstein R, Rothenberger A, Banaschewski R, Oades R, McGough J, Nisenbaum L, Middleton F, Hu X, Nelson S, Kent L, Williams N, Owen M, Holmans P, O'Donovan M, Thapar A. 2013. High loading of polygenic risk for ADHD in those with comorbid aggression. Am J Psychiatry [Epub ahead of print].
38. Hawi Z, McCarron M, Kirley A, Daly G, Fitzgerald M, Gill M. 2000. No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population. Am J Med Genet Part B 96:268-272.
39. Hebebrand J, Dempfle A, Saar K, Thiele H, Herpertz-Dahlmann B, Linder M, Kiefl H, Remschmidt H, Hemminger U, Warnke A, Knolker U, Heiser P, Friedel S, Hinney A, Schafer H, Nurnberg P, Konrad K. 2006. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol Psychiatry 11:196-205.
40. Hewitt J, Rutter M, Somonoff E, Pickles A, Loeber R, Heath A, Reynolds C, Silberg J, Meyer J, Maes H, Erickson M, Kendler K, Truett K, Eaves L. 1997. Genetics and developmental psychopathology 1. Phenotypic assessment in the Virginia twin study of adolescent behavioral development. J Child Psychol Psychiatry 38:943-963.
41. Hollingshead AB. 1975. Four factor index of social status. New Haven: Yale Press.
42. Hoza B. 2007. Peer functioning in children with ADHD. J Pediatr Psychol 32:655-663.
43. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. 2001. Replication validity of genetic association studies. Nat Genet 29:306-309.
44. Jastak JF, Jastak S. 1985. The wide range achievement test-Revised. Wilmington, DE: Jastak Associates.
45. Kendler KS, Prescott CA, Myers J, Neale MC. 2003. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 60:929-937.
46. Kent L, Doerry U, Hardy E, Parmar R, Gingell K, Hawi Z, Kirley A, Lowe N, Fitzgerald M, Gill M, Craddock N. 2002. Evidence that variation at the serotonin transprter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): Analysis and pooled analysis. Mol Psychiatry 7:908-912.
47. Krueger RF. 1999. The structure of common mental disorders. Arch Gen Psychiatry 56:921-926.
48. Kumsta R, Stevens S, Brookes K, Schlotz W, Castle J, Beckett C, Kreppner J, Rutter M, Sonuga-Barke E. 2010. 5HTT genotype moderates the influence of early institutional deprivation on emotional problems in adolescence: Evidence from the English and Romanian adoptee (era) study. J Child Psychol Psychiatry 51:755-762.
49. Lahey BB, Rathouz PJ, Lee SS, Chronis-Tuscano A, Pelham WE, Waldman ID, Cook EH. 2011. Interactions between early parenting and a polymorphism of the child's dopamine transporter gene in predicting future child conduct disorder symptoms. J Abnorm Psychol 120:33-45.
50. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL. 1996. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1:121-124.
51. Lander ES, Schork NJ. 1994. Genetic dissection of complex traits. Science 265:2037-2048.
52. Langley K, Payton A, Hamshere ML, Pay HM, Lawson DC, Turic D, Ollier W, Worthington J, Owen MJ, O'Donovan MC, Thapar A. 2003. No evidence of association of two 5HT transporter gene polymorphisms and attention deficit hyperactivity disorder. Psychiatr Genet 13:107-110.
53. Langley K, Fowler TA, Grady DL, Moyzis RK, Holmans PA, van den Bree MB, Owen MJ, O'Donovan MC, Thapar A. 2009. Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder. Eur Child Adolesc Psychiatry 18:26-32.
54. Lasky-Su J, Neale BM, Franke B, Anney RJ, Zhou K, Maller JB, Vasquez AA, Chen W, Asherson P, Buitelaar J, Banaschewski T, Ebstein R, Gill M, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen HC, Taylor E, Daly M, Laird N, Lange C, Faraone SV. 2008. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet Part B 147B:1345-1354.
55. Lesch KP, Timmesfeld N, Renner TJ, Halperin R, Roser C, Nguyen TT, Craig DW, Romanos J, Heine M, Meyer J, Freitag C, Warnke A, Romanos M, Schafer H, Walitza S, Reif A, Stephan DA, Jacob C. 2008. Molecular genetics of adult ADHD: Converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 115:1573-1585.
56. Li JJ, Lee SS. 2012. Interaction of dopamine transporter gene and observed parenting behaviors on attention-deficit/hyperactivity disorder: A structural equation modeling approach. J Clin Child Adolesc Psychol 42:174-186.
57. Licinio J. 1996. The dopamine D4 receptor and attention deficit hyperactivity disorder. Mol Psychiatry 1:83-84.
58. Loe IM, Feldman HM. 2007. Academic and educational outcomes of children with ADHD. Ambul Pediatr 7:82-90.
59. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182.
60. Manor I, Eisenberg J, Tyano S, Sever Y, Cohen H, Ebstein RP, Kotler M. 2001. Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. Am J Med Genet 105:91-95.
61. Mick E, Faraone SV. 2008. Genetics of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 17:261-284; vii-viii.
62. Mick E, Neale B, Middleton FA, McGough JJ, Faraone SV. 2008. Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder. Am J Med Genet Part B 147B:1412-1418.
63. Milberger S, Biederman J, Faraone SV, Guite J, Tsuang MT. 1997. Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: Issues of gene-environment interaction. Biol Psychiatry 41:65-75.
64. Mill J, Caspi A, Williams BS, Craig I, Taylor A, Polo-Tomas M, Berridge CW, Poulton R, Moffitt TE. 2006. Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: Evidence from 2 birth cohorts. Arch Gen Psychiatry 63:462-469.
65. Monuteaux MC, Faraone SV, Gross LM, Biederman J. 2007. Predictors, course, and outcome of conduct disorder in girls with attention-deficit/hyperactivity disorder: A longitudinal study. Psychol Med 37(12):1731-1741.
66. Monuteaux MC, Biederman J, Doyle AE, Mick E, Faraone SV. 2009. Genetic risk for conduct disorder symptom subtypes in an ADHD sample: Specificity to aggressive symptoms. J Am Acad Child Adolesc Psychiatry 48:757-764.
67. Neale BM, Lasky-Su J, Anney R, Franke B, Zhou K, Maller JB, Vasquez AA, Asherson P, Chen W, Banaschewski T, Buitelaar J, Ebstein R, Gill M, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke E, Mulas F, Taylor E, Laird N, Lange C, Daly M, Faraone SV. 2008. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet Part B 147B:1337-1344.
68. Neale BM, Medland S, Ripke S, Anney RJ, Asherson P, Buitelaar J, Franke B, Gill M, Kent L, Holmans P, Middleton F, Thapar A, Lesch KP, Faraone SV, Daly M, Nguyen TT, Schafer H, Steinhausen HC, Reif A, Renner TJ, Romanos M, Romanos J, Warnke A, Walitza S, Freitag C, Meyer J, Palmason H, Rothenberger A, Hawi Z, Sergeant J, Roeyers H, Mick E, Biederman J, Group IIC. 2010. Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49:906-920.
69. Nijmeijer JS, Hartman CA, Rommelse NN, Altink ME, Buschgens CJ, Fliers EA, Franke B, Minderaa RB, Ormel J, Sergeant JA, Verhulst FC, Buitelaar JK, Hoekstra PJ. 2010. Perinatal risk factors interacting with catechol-O-methyltransferase and the serotonin transporter gene predict ASD symptoms in children with ADHD. J Child Psychol Psychiatry 51:1242-1250.
70. Nikolas M, Klump KL, Burt SA. 2012. Youth appraisals of inter-parental conflict and genetic and environmental contributions to attention-deficit hyperactivity disorder: Examination of G×E effects in a twin sample. J Abnorm Child Psychol 40:543-554.
71. O'Connell RG, Bellgrove MA, Dockree PM, Lau A, Hester R, Garavan H, Fitzgerald M, Foxe JJ, Robertson IH. 2009. The Neural Correlates of deficient error awareness in attention-deficit hyperactivity disroder (ADHD). Neuropsychologia 47:1149-1159.
72. Ogdie MN, Bakker SC, Fisher SE, Francks C, Yang MH, Cantor RM, Loo SK, van der Meulen E, Pearson P, Buitelaar J, Monaco A, Nelson SF, Sinke RJ, Smalley SL. 2006. Pooled genome-wide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13. Mol Psychiatry 11:5-8.
73. Orvaschel H. 1985. Psychiatric interviews suitable for use in research with children and adolescents. Psychopharmacol Bull 21:737-745.
74. Orvaschel H, Puig-Antich J. 1987. Schedule for affective disorders and schizophrenia for school-age children: Epidemiologic version. Fort Lauderdale, FL: Nova University.
75. Propper C, Willoughby M, Halpern CT, Carbone MA, Cox M. 2007. Parenting quality, DRD4, and the prediction of externalizing and internalizing behaviors in early childhood. Dev Psychobiol 49:619-632.
76. Rannala B. 2001. Finding genes influencing susceptibility to complex diseases in the post-genome era. Am J Pharmacogenomics 1:203-221.
77. Rice JP, Saccone NL, Rasmussen E. 2001. Definition of the phenotype. Adv Genet 42:69-76.
78. Risch N, Merikangas K. 1996. The future of genetic studies of complex human diseases. Science 273:1516-1517.
79. Rowe DC, Stever C, Giedinghagen LN, Gard JM, Cleveland HH, Terris ST, Mohr JH, Sherman S, Abramowitz A, Waldman ID. 1998. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 3:419-426.
80. Salatino-Oliveira A, Genro JP, Zeni C, Polanczyk GV, Chazan R, Guimaraes AP, Callegari-Jacques SM, Rohde LA, Hutz MH. 2011. Catechol-O-methyltransferase Valine158Methionine polymorphism moderates methylphenidate effects on oppositional symptoms in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry 70:216-221.
81. Salatino-Oliveira A, Genro JP, Guimaraes AP, Chazan R, Zeni C, Schmitz M, Polanczyk G, Roman T, Rohde LA, Hutz MH. 2012. Cathechol-O-methyltransferase Val(158)Met polymorphism is associated with disruptive behavior disorders among children and adolescents with ADHD. J Neural Transm 119:729-733.
82. Sattler J. 1988. Psychological assessment. New York: McGraw-Hill.
83. Seeger G, Schloss P, Schmidt MH. 2001. Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders. Mol Psychiatry 6:235-238.
84. Shaw P, Gornick M, Lerch J, Addington A, Seal J, Greenstein D, Sharp W, Evans A, Giedd JN, Castellanos FX, Rapoport JL. 2007. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64:921-931.
85. Sklar P. 2005. Principles of haplotype mapping and potential applications to attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1357-1366.
86. Sonuga-Barke EJ, Oades RD, Psychogiou L, Chen W, Franke B, Buitelaar J, Banaschewski T, Ebstein RP, Gil M, Anney R, Miranda A, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Thompson M, Asherson P, Faraone SV. 2009. Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: The case of conduct and emotional problems in attention deficit/hyperactivity disorder. J Child Psychol Psychiatry 50:1052-1063.
87. Spencer TJ, Faraone SV, Surman CB, Petty C, Clarke A, Batchelder H, Wozniak J, Biederman J. 2011. Toward defining deficient emotional self-regulation in children with attention-deficit/hyperactivity disorder using the Child Behavior Checklist: A controlled study. Postgrad Med 123:50-59.
88. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S, Murias M, Moriarity J, Barr C, Smith M, Posner M. 2000. Dopamine genes and ADHD. Neurosci Biobehav Rev 24:21-25.
89. Thakur GA, Sengupta SM, Grizenko N, Choudhry Z, Joober R. 2012. Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: Relation to maternal smoking during pregnancy. PLoS ONE 7:e49616.
90. Todd RD, Jong YJ, Lobos EA, Reich W, Heath AC, Neuman RJ. 2001. No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins. Am J Med Genet 105:745-748.
91. van den Hoofdakker BJ, Nauta MH, Dijck-Brouwer DA, van der Veen-Mulders L, Sytema S, Emmelkamp PM, Minderaa RB, Hoekstra PJ. 2012. Dopamine transporter gene moderates response to behavioral parent training in children with ADHD: A pilot study. Dev Psychol 48:567-574.
92. Waldman ID, Gizer IR. 2006. The genetics of attention deficit hyperactivity disorder. Clin Psychol Rev 26:396-432.
93. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders ML, Gard JM, Stever C. 1998. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 63:1767-1776.
94. Wechsler D. 1974. Manual for the Wechsler intelligence scale for children-Revised. New York: The Psychological Corporation.
95. Wigg KG, Takhar A, Ickowicz A, Tannock R, Kennedy JL, Pathare T, Malone M, Schachar R, Barr CL. 2006. Gene for the serotonin transporter and ADHD: No association with two functional polymorphisms. Am J Med Genet Part B 141B:566-570.
96. Wozniak J, Biederman J, Kwon A, Mick E, Faraone S, Orlovsky K, Schnare L, Cargol C, van Grondelle A. 2005. How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates. Biol Psychiatry 58:583-588.
97. Xu X, Mill J, Chen CK, Brookes K, Taylor E, Asherson P. 2005. Family-based association study of serotonin transporter gene polymorphisms in attention deficit hyperactivity disorder: No evidence for association in UK and Taiwanese samples. Am J Med Genet Part B 139:11-13.